Status:

WITHDRAWN

A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease

Lead Sponsor:

University of Kentucky

Collaborating Sponsors:

American Diabetes Association

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

40-55 years

Brief Summary

The purpose of this research is to better understand how calcium and glucose may play a role in people developing diabetes. By doing this study, the investigator hopes to learn whether abnormal calciu...

Detailed Description

The overall goal of this proposal is to establish a pathophysiological index of a patient's status through imaging of calcium and glucose in skin fibroblasts. The investigator will obtain skin samples...

Eligibility Criteria

Inclusion

  • Healthy
  • Type 2 Diabetes

Exclusion

  • Under 40 years of age
  • Over 55 years of age
  • Pregnant or breastfeedig
  • Will not agree to a skin biopsy
  • Talking calcium channel blockers

Key Trial Info

Start Date :

October 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01917669

Start Date

October 1 2013

End Date

September 1 2016

Last Update

October 25 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Kentucky Center for Clinical and Translational Science

Lexington, Kentucky, United States, 40536